AZTR
Price:
$0.3708
Market Cap:
$3.78M
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
Industry
Biotechnology
IPO Date
2023-06-20
Stock Exchange
AMEX
Ticker
AZTR
According to Azitra, Inc.’s latest financial reports and current stock price. The company's current ROE is -516.85%. This represents a change of -97.04% compared to the average of -17444.48% of the last 4 quarters.
The mean historical ROE of Azitra, Inc. over the last ten years is -120.14%. The current -516.85% ROE has changed 330.21% with respect to the historical average. Over the past ten years (40 quarters), AZTR's ROE was at its highest in in the December 2022 quarter at 11.16%. The ROE was at its lowest in in the March 2025 quarter at -69614.49%.
Average
-120.14%
Median
-63.96%
Minimum
-387.34%
Maximum
34.70%
Discovering the peaks and valleys of Azitra, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 34.70%
Minimum Annual Increase = -1415.04%
Minimum Annual ROE = -387.34%
| Year | ROE | Change |
|---|---|---|
| 2024 | -157.37% | -59.37% |
| 2023 | -387.34% | -1415.04% |
| 2022 | 29.45% | -15.11% |
The current ROE of Azitra, Inc. (AZTR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-171.75%
5-year avg
-120.14%
10-year avg
-120.14%
Azitra, Inc.’s ROE is greater than Onconetix, Inc. (-839.59%), greater than Jasper Therapeutics, Inc. (-121.65%), greater than SciSparc Ltd. (-83.38%), less than Silexion Therapeutics Ltd. (1.22%), greater than Indaptus Therapeutics, Inc. (-612.63%), less than Scinai Immunotherapeutics Ltd. (51.65%), greater than Salarius Pharmaceuticals, Inc. (-401.03%), greater than Revelation Biosciences, Inc. (-194.47%), greater than Lipella Pharmaceuticals Inc. (-685.24%), greater than Enveric Biosciences, Inc. (-341.49%),
| Company | ROE | Market cap |
|---|---|---|
| -839.59% | $1.64M | |
| -121.65% | $29.58M | |
| -83.38% | $888.48K | |
| 1.22% | $1.76M | |
| -612.63% | $3.78M | |
| 51.65% | $1.41M | |
| -401.03% | $5.04M | |
| -194.47% | $6.10M | |
| -685.24% | $1.43M | |
| -341.49% | $3.57M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Azitra, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Azitra, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Azitra, Inc.'s ROE?
How is the ROE calculated for Azitra, Inc. (AZTR)?
What is the highest ROE for Azitra, Inc. (AZTR)?
What is the 3-year average ROE for Azitra, Inc. (AZTR)?
What is the 5-year average ROE for Azitra, Inc. (AZTR)?
How does the current ROE for Azitra, Inc. (AZTR) compare to its historical average?